Difference between revisions of "Physiology"
| (6 intermediate revisions by the same user not shown) | |||
| Line 6: | Line 6: | ||
[[File:Sumhorsa.gif|center|Sumhorsa.gif]] | [[File:Sumhorsa.gif|center|Sumhorsa.gif]] | ||
| − | <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 150%; text-align: center;">'''Dealing with the physiology or pharmacology of compression and/or hyperoxygenation + the postoperative use of HBOT''' | + | <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 150%; text-align: center;">'''Dealing with the physiology or pharmacology of compression and/or hyperoxygenation + the postoperative use of HBOT'''</span> |
[[File:Sumhorsa.gif|center|Sumhorsa.gif]] | [[File:Sumhorsa.gif|center|Sumhorsa.gif]] | ||
| Line 12: | Line 12: | ||
<span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 130%; text-align: center;">Subject last searched June 2017. Next search January 2022</span> | <span style="display: block; font-family: arial,helvetica,sans-serif; font-size: 130%; text-align: center;">Subject last searched June 2017. Next search January 2022</span> | ||
| − | {| | + | |
| + | |||
| + | | ||
| + | |||
| + | | ||
| + | |||
| + | {| class="Table" style="border: 1pt solid windowtext; width: 929px;" | ||
|- | |- | ||
| − | | '''<span>Author 1</span>''' | + | | style="width:40.05pt; border:solid windowtext 1.0pt" width="53" | <p style="margin-bottom: 0cm; padding: 0.75pt; text-align: center;"><span style="line-height:normal">'''<span style="font-family:">Author 1</span>'''</span></p> |
| − | | '''<span>Author 2</span>''' | + | | style="width:41.0pt; border:solid windowtext 1.0pt" width="55" | <p style="margin-bottom: 0cm; padding: 0.75pt; text-align: center;"><span style="line-height:normal">'''<span style="font-family:">Author 2</span>'''</span></p> |
| − | | '''<span>Author 3</span>''' | + | | style="width:41.05pt; border:solid windowtext 1.0pt" width="55" | <p style="margin-bottom: 0cm; padding: 0.75pt; text-align: center;"><span style="line-height:normal">'''<span style="font-family:">Author 3</span>'''</span></p> |
| − | | '''<span>Title</span>''' | + | | style="width: 221px; border: 1pt solid windowtext;" width="121" | <p style="margin-bottom: 0cm; padding: 0.75pt; text-align: center;"><span style="line-height:normal">'''<span style="font-family:">Title</span>'''</span></p> |
| − | | '''<span>Citation</span>''' | + | | style="width: 93px; border: 1pt solid windowtext;" width="74" | <p style="margin-bottom: 0cm; padding: 0.75pt; text-align: center;"><span style="line-height:normal">'''<span style="font-family:">Citation</span>'''</span></p> |
| − | | '''<span>Keyword 1</span>''' | + | | style="width: 153px; border: 1pt solid windowtext;" width="74" | <p style="margin-bottom: 0cm; padding: 0.75pt; text-align: center;"><span style="line-height:normal">'''<span style="font-family:">Keyword 1</span>'''</span></p> |
| − | | '''<span>Keyword 2</span>''' | + | | style="width: 125px; border: 1pt solid windowtext;" width="76" | <p style="margin-bottom: 0cm; padding: 0.75pt; text-align: center;"><span style="line-height:normal">'''<span style="font-family:">Keyword 2</span>'''</span></p> |
| − | | '''<span>Keyword 3</span>''' | + | | style="width: 100px; border: 1pt solid windowtext;" width="76" | <p style="margin-bottom: 0cm; padding: 0.75pt; text-align: center;"><span style="line-height:normal">'''<span style="font-family:">Keyword 3</span>'''</span></p> |
|- | |- | ||
| − | | <span>[[Merritt|Merritt GJ]]</span> | + | | style="width:40.05pt; border:solid windowtext 1.0pt" width="53" | |
| − | | <span>Slade JB</span> | + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">[[Merritt|<span style="color:blue">Merritt GJ</span>]]</span></span></span> |
| − | | | + | |
| − | | <span>Influence of hyperbaric oxygen on the pharmacokinetics of single-dose gentamicin in healthy volunteers.</span> | + | | style="width:41.0pt; border:solid windowtext 1.0pt" width="55" | |
| − | | <span>Pharmacotherapy 1993;13(4):382-5.</span> | + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Slade JB</span></span></span> |
| − | | <span>Gentamicin</span> | + | |
| − | | | + | | style="width: 41.05pt; border: 1pt solid windowtext; padding: 0.75pt;" width="55" | |
| − | | <span>Pharmacokinetics</span> | + | | style="width: 221px; border: 1pt solid windowtext;" width="121" | |
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Influence of hyperbaric oxygen on the pharmacokinetics of single-dose gentamicin in healthy volunteers.</span></span></span> | ||
| + | |||
| + | | style="width: 93px; border: 1pt solid windowtext;" width="74" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Pharmacotherapy 1993;13(4):382-5.</span></span></span> | ||
| + | |||
| + | | style="width: 153px; border: 1pt solid windowtext;" width="74" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Gentamicin</span></span></span> | ||
| + | |||
| + | | style="width: 125px; border: 1pt solid windowtext; padding: 0.75pt;" width="76" | | ||
| + | | style="width: 100px; border: 1pt solid windowtext;" width="76" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Pharmacokinetics</span></span></span> | ||
| + | |||
|- | |- | ||
| − | | <span>[[Pelai|Peliai P]]</span> | + | | style="width:40.05pt; border:solid windowtext 1.0pt" width="53" | |
| − | | <span>Rocco M</span> | + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">[[Pelai|<span style="color:blue">Peliai P</span>]]</span></span></span> |
| − | | <span>De Blasi R</span> | + | |
| − | | <span>Assessment of lipid peroxidation in hyperbaric oxygen therapy: protective role of N-acetylcysteine.</span> | + | | style="width:41.0pt; border:solid windowtext 1.0pt" width="55" | |
| − | | <span>Minerva Anestesiologia 1995; 61:133-139.</span> | + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Rocco M</span></span></span> |
| − | | <span>Acetylcysteine</span> | + | |
| − | | <span>Lipid Peroxidation</span> | + | | style="width:41.05pt; border:solid windowtext 1.0pt" width="55" | |
| − | | <span>Free Radicals</span> | + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">De Blasi R</span></span></span> |
| + | |||
| + | | style="width: 221px; border: 1pt solid windowtext;" width="121" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Assessment of lipid peroxidation in hyperbaric oxygen therapy: protective role of N-acetylcysteine.</span></span></span> | ||
| + | |||
| + | | style="width: 93px; border: 1pt solid windowtext;" width="74" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Minerva Anestesiologia 1995; 61:133-139.</span></span></span> | ||
| + | |||
| + | | style="width: 153px; border: 1pt solid windowtext;" width="74" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Acetylcysteine</span></span></span> | ||
| + | |||
| + | | style="width: 125px; border: 1pt solid windowtext;" width="76" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Lipid Peroxidation</span></span></span> | ||
| + | |||
| + | | style="width: 100px; border: 1pt solid windowtext;" width="76" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Free Radicals</span></span></span> | ||
| + | |||
|- | |- | ||
| − | | <span>[[Shupak|Shupak A]]</span> | + | | style="width:40.05pt; border:solid windowtext 1.0pt" width="53" | |
| − | | <span>Abramovich A</span> | + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">[[Shupak|<span style="color:blue">Shupak A</span>]]</span></span></span> |
| − | | <span>Adir Y</span> | + | |
| − | | <span>Effects on pulmonary function of daily exposure to dry or humidified hyperbaric oxygen.</span> | + | | style="width:41.0pt; border:solid windowtext 1.0pt" width="55" | |
| − | | <span>Respiratory Physiology 1997; 108:241-246.</span> | + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Abramovich A</span></span></span> |
| − | | <span>Humidity</span> | + | |
| − | | | + | | style="width:41.05pt; border:solid windowtext 1.0pt" width="55" | |
| − | | <span style="font-size: | + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Adir Y</span></span></span> |
| + | |||
| + | | style="width: 221px; border: 1pt solid windowtext;" width="121" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Effects on pulmonary function of daily exposure to dry or humidified hyperbaric oxygen.</span></span></span> | ||
| + | |||
| + | | style="width: 93px; border: 1pt solid windowtext;" width="74" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Respiratory Physiology 1997; 108:241-246.</span></span></span> | ||
| + | |||
| + | | style="width: 153px; border: 1pt solid windowtext;" width="74" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Humidity</span></span></span> | ||
| + | |||
| + | | style="width: 125px; border: 1pt solid windowtext; padding: 0.75pt;" width="76" | | ||
| + | | style="width: 100px; border: 1pt solid windowtext;" width="76" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Respiratory Mechanics</span></span></span> | ||
| + | |||
|- | |- | ||
| − | | <span>[[Thomas|Thomas PS]]</span> | + | | style="width:40.05pt; border:solid windowtext 1.0pt" width="53" | |
| − | | <span>Hakim TS</span> | + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">[[Thomas|<span style="color:blue">Thomas PS</span>]]</span></span></span> |
| − | | <span>Trang LQ</span> | + | |
| − | | <span>The synergistic effect of sympathectomy and hyperbaric oxygen exposure on transcutaneous PO2 in healthy volunteers</span> | + | | style="width:41.0pt; border:solid windowtext 1.0pt" width="55" | |
| − | | <span>Anesthesia and Analgesia 1999; 88:67-71</span> | + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Hakim TS</span></span></span> |
| − | | <span>Nerve Block</span> | + | |
| − | | <span>*Sympathectomy/Chemical</span> | + | | style="width:41.05pt; border:solid windowtext 1.0pt" width="55" | |
| − | | <span>Blood Gas Monitoring, Transcutaneous</span> | + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Trang LQ</span></span></span> |
| + | |||
| + | | style="width: 221px; border: 1pt solid windowtext;" width="121" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">The synergistic effect of sympathectomy and hyperbaric oxygen exposure on transcutaneous PO2 in healthy volunteers</span></span></span> | ||
| + | |||
| + | | style="width: 93px; border: 1pt solid windowtext;" width="74" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Anesthesia and Analgesia 1999; 88:67-71</span></span></span> | ||
| + | |||
| + | | style="width: 153px; border: 1pt solid windowtext;" width="74" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Nerve Block</span></span></span> | ||
| + | |||
| + | | style="width: 125px; border: 1pt solid windowtext;" width="76" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">*Sympathectomy/Chemical</span></span></span> | ||
| + | |||
| + | | style="width: 100px; border: 1pt solid windowtext;" width="76" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Blood Gas Monitoring, Transcutaneous</span></span></span> | ||
| + | |||
|- | |- | ||
| − | | <span>[[Stephens|Stephens M]]</span> | + | | style="width:40.05pt; border:solid windowtext 1.0pt" width="53" | |
| − | | <span>Frey M</span> | + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">[[Stephens|<span style="color:blue">Stephens M</span>]]</span></span></span> |
| − | | <span>Mohler S</span> | + | |
| − | | <span>Effect of caffeine consumption on tissue oxygen levels during hyperbaric oxygen treatment.</span> | + | | style="width:41.0pt; border:solid windowtext 1.0pt" width="55" | |
| − | | <span>Undersea and Hyperbaric Medicine 1999; 26:93-97.</span> | + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Frey M</span></span></span> |
| − | | <span>Caffeine/administration</span> | + | |
| − | | | + | | style="width:41.05pt; border:solid windowtext 1.0pt" width="55" | |
| − | | <span style="font-size: | + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Mohler S</span></span></span> |
| + | |||
| + | | style="width: 221px; border: 1pt solid windowtext;" width="121" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Effect of caffeine consumption on tissue oxygen levels during hyperbaric oxygen treatment.</span></span></span> | ||
| + | |||
| + | | style="width: 93px; border: 1pt solid windowtext;" width="74" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Undersea and Hyperbaric Medicine 1999; 26:93-97.</span></span></span> | ||
| + | |||
| + | | style="width: 153px; border: 1pt solid windowtext;" width="74" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Caffeine/administration</span></span></span> | ||
| + | |||
| + | | style="width: 125px; border: 1pt solid windowtext; padding: 0.75pt;" width="76" | | ||
| + | | style="width: 100px; border: 1pt solid windowtext;" width="76" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Blood gas monitoring, transcutaneous</span></span></span> | ||
| + | |||
|- | |- | ||
| − | | <span>[[Ueno|Ueno S]]</span> | + | | style="width:40.05pt; border:solid windowtext 1.0pt" width="53" | |
| − | | <span>Tanabe G</span> | + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">[[Ueno|<span style="color:blue">Ueno S</span>]]</span></span></span> |
| − | | <span>Kihara K</span> | + | |
| − | | <span>Early post-operative hyperbaric oxygen therapy modifies neutrophile activation</span> | + | | style="width:41.0pt; border:solid windowtext 1.0pt" width="55" | |
| − | | <span>Hepato-Gastroenterology 1999; 46:1798-1799</span> | + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Tanabe G</span></span></span> |
| − | | <span>Neutrophil</span> | + | |
| − | | <span>Hepatectomy</span> | + | | style="width:41.05pt; border:solid windowtext 1.0pt" width="55" | |
| − | | <span>Endothelium</span> | + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Kihara K</span></span></span> |
| + | |||
| + | | style="width: 221px; border: 1pt solid windowtext;" width="121" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Early post-operative hyperbaric oxygen therapy modifies neutrophile activation</span></span></span> | ||
| + | |||
| + | | style="width: 93px; border: 1pt solid windowtext;" width="74" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Hepato-Gastroenterology 1999; 46:1798-1799</span></span></span> | ||
| + | |||
| + | | style="width: 153px; border: 1pt solid windowtext;" width="74" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Neutrophil</span></span></span> | ||
| + | |||
| + | | style="width: 125px; border: 1pt solid windowtext;" width="76" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Hepatectomy</span></span></span> | ||
| + | |||
| + | | style="width: 100px; border: 1pt solid windowtext;" width="76" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Endothelium</span></span></span> | ||
| + | |||
|- | |- | ||
| − | | <span>[[Jansen|Jansen T]]</span> | + | | style="width:40.05pt; border:solid windowtext 1.0pt" width="53" | |
| − | | <span>Mortensen CR</span> | + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">[[Jansen|<span style="color:blue">Jansen T</span>]]</span></span></span> |
| − | | <span>Tvede MF</span> | + | |
| − | | <span>It is possible to perform a double-blind hyperbaric session: A double-blinded randomized trial performed on healthy volunteers.</span> | + | | style="width:41.0pt; border:solid windowtext 1.0pt" width="55" | |
| − | | <span>Undersea and Hyperbaric Medicine 2009;36(5):347-351</span> | + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Mortensen CR</span></span></span> |
| − | | <span>Blinding</span> | + | |
| − | | <span>Trial methodology</span> | + | | style="width:41.05pt; border:solid windowtext 1.0pt" width="55" | |
| − | | <span>RCT</span> | + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Tvede MF</span></span></span> |
| + | |||
| + | | style="width: 221px; border: 1pt solid windowtext;" width="121" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">It is possible to perform a double-blind hyperbaric session: A double-blinded randomized trial performed on healthy volunteers.</span></span></span> | ||
| + | |||
| + | | style="width: 93px; border: 1pt solid windowtext;" width="74" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Undersea and Hyperbaric Medicine 2009;36(5):347-351</span></span></span> | ||
| + | |||
| + | | style="width: 153px; border: 1pt solid windowtext;" width="74" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Blinding</span></span></span> | ||
| + | |||
| + | | style="width: 125px; border: 1pt solid windowtext;" width="76" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Trial methodology</span></span></span> | ||
| + | |||
| + | | style="width: 100px; border: 1pt solid windowtext;" width="76" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">RCT</span></span></span> | ||
| + | |||
|- | |- | ||
| − | | <span>[[Ueno2|Ueno S]]</span> | + | | style="width:40.05pt; border:solid windowtext 1.0pt" width="53" | |
| − | | <span>Sakoda M</span> | + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">[[Ueno2|<span style="color:blue">Ueno S</span>]]</span></span></span> |
| − | | <span>Kurahara H</span> | + | |
| − | | <span>Safety and efficacy of early postoperative hyperbaric oxygen therapy with restriction of transfusions in patients with HCC who have undergone partial hepatectomy.</span> | + | | style="width:41.0pt; border:solid windowtext 1.0pt" width="55" | |
| − | | <span>Langenbeck's archives of surgery. 2011 Jan 1;396(1):99-106</span> | + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Sakoda M</span></span></span> |
| − | | <span>Hepatectomy</span> | + | |
| − | | <span>Serum Lactate</span> | + | | style="width:41.05pt; border:solid windowtext 1.0pt" width="55" | |
| − | | <span>Complications</span> | + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Kurahara H</span></span></span> |
| + | |||
| + | | style="width: 221px; border: 1pt solid windowtext;" width="121" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Safety and efficacy of early postoperative hyperbaric oxygen therapy with restriction of transfusions in patients with HCC who have undergone partial hepatectomy.</span></span></span> | ||
| + | |||
| + | | style="width: 93px; border: 1pt solid windowtext;" width="74" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Langenbeck's archives of surgery. 2011 Jan 1;396(1):99-106</span></span></span> | ||
| + | |||
| + | | style="width: 153px; border: 1pt solid windowtext;" width="74" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Hepatectomy</span></span></span> | ||
| + | |||
| + | | style="width: 125px; border: 1pt solid windowtext;" width="76" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Serum Lactate</span></span></span> | ||
| + | |||
| + | | style="width: 100px; border: 1pt solid windowtext;" width="76" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Complications</span></span></span> | ||
| + | |||
|- | |- | ||
| − | | <span>[[Chiles|Chiles KA]]</span> | + | | style="width:40.05pt; border:solid windowtext 1.0pt" width="53" | |
| − | | <span>Staff I</span> | + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">[[Chiles|<span style="color:blue">Chiles KA</span>]]</span></span></span> |
| − | | <span>Johnson-Arbor K</span> | + | |
| − | | <span>A Double-Blind, Randomized Trial on the Efficacy and Safety of Hyperbaric Oxygenation Therapy in the Preservation of Erectile Function after Radical Prostatectomy.</span> | + | | style="width:41.0pt; border:solid windowtext 1.0pt" width="55" | |
| − | | <span>The Journal of Urology 2018; 199:805-811.</span> | + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Staff I</span></span></span> |
| − | | <span>Prostatectomy</span> | + | |
| − | | <span>Erectile dysfunction</span> | + | | style="width:41.05pt; border:solid windowtext 1.0pt" width="55" | |
| − | | <span>Quality of Life</span> | + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Johnson-Arbor K</span></span></span> |
| + | |||
| + | | style="width: 221px; border: 1pt solid windowtext;" width="121" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">A Double-Blind, Randomized Trial on the Efficacy and Safety of Hyperbaric Oxygenation Therapy in the Preservation of Erectile Function after Radical Prostatectomy.</span></span></span> | ||
| + | |||
| + | | style="width: 93px; border: 1pt solid windowtext;" width="74" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">The Journal of Urology 2018; 199:805-811.</span></span></span> | ||
| + | |||
| + | | style="width: 153px; border: 1pt solid windowtext;" width="74" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Prostatectomy</span></span></span> | ||
| + | |||
| + | | style="width: 125px; border: 1pt solid windowtext;" width="76" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Erectile dysfunction</span></span></span> | ||
| + | |||
| + | | style="width: 100px; border: 1pt solid windowtext;" width="76" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Quality of Life</span></span></span> | ||
| + | |||
|- | |- | ||
| − | | Martinelli B | + | | style="width:40.05pt; border:solid windowtext 1.0pt" width="53" | |
| − | | Noronha JM | + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">[[Martinelli|<span style="color:blue">Martinelli B</span>]]</span></span></span> |
| − | | Sette MF | + | |
| − | | Cardiorespiratory alterations in patients undergoing hyperbaric oxygen therapy. | + | | style="width:41.0pt; border:solid windowtext 1.0pt" width="55" | |
| − | | Revista da Escola de Enfermagem da USP. 2019 Sep;53:e03469 | + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Noronha JM</span></span></span> |
| − | | Oxygen saturation | + | |
| − | | Heart rate | + | | style="width:41.05pt; border:solid windowtext 1.0pt" width="55" | |
| − | + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Sette MF</span></span></span> | |
| − | + | ||
| + | | style="width: 221px; border: 1pt solid windowtext;" width="121" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Cardiorespiratory alterations in patients undergoing hyperbaric oxygen therapy.</span></span></span> | ||
| + | |||
| + | | style="width: 93px; border: 1pt solid windowtext;" width="74" | | ||
| + | <span style="line-height:normal"><span lang="ES" style="font-size:10.0pt"><span style="font-family:">Revista da Escola de Enfermagem da USP. 2019 Sep;53:e03469</span></span></span> | ||
| + | |||
| + | | style="width: 153px; border: 1pt solid windowtext;" width="74" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Oxygen saturation</span></span></span> | ||
| + | |||
| + | | style="width: 125px; border: 1pt solid windowtext;" width="76" | | ||
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Heart rate</span></span></span> | ||
| − | <span style=" | + | | style="width: 100px; border: 1pt solid windowtext;" width="76" | |
| + | <span style="line-height:normal"><span style="font-size:10.0pt"><span style="font-family:">Respiratory</span></span></span> | ||
| + | |- | ||
| + | | style="width:40.05pt; border:solid windowtext 1.0pt" width="53" | [[Chen3|Chen F]] | ||
| + | | style="width:41.0pt; border:solid windowtext 1.0pt" width="55" | Sun H | ||
| + | | style="width:41.05pt; border:solid windowtext 1.0pt" width="55" | Jia B | ||
| + | | style="width: 221px; border: 1pt solid windowtext;" width="121" | Clinical studies on the use of hyperbaric oxygen in replantation of young permanent teeth. | ||
| + | | style="width: 93px; border: 1pt solid windowtext;" width="74" | Zhonghua kou qiang yi xue za zhi= Zhonghua kouqiang yixue zazhi= Chinese journal of stomatology. 2000 Jul 1;35(4):271-3 | ||
| + | | style="width: 153px; border: 1pt solid windowtext;" width="74" | tooth implantation | ||
| + | | style="width: 125px; border: 1pt solid windowtext;" width="76" | dentistry | ||
| + | | style="width: 100px; border: 1pt solid windowtext;" width="76" | Re-implantation | ||
| + | |- | ||
| + | | style="width:40.05pt; border:solid windowtext 1.0pt" width="53" | [[Cardenas|Cardenas Ureña KG]] | ||
| + | | style="width:41.0pt; border:solid windowtext 1.0pt" width="55" | Ramírez Nava JC | ||
| + | | style="width:41.05pt; border:solid windowtext 1.0pt" width="55" | Márquez Celedonio FG | ||
| + | | style="width: 221px; border: 1pt solid windowtext;" width="121" | Clinical efficacy of adjuvant therapy with hyperbaric oxygen in diabetic nephropathy. | ||
| + | | style="width: 93px; border: 1pt solid windowtext;" width="74" | Undersea & Hyperbaric Medicine 2020, 47(3): 415-422. | ||
| + | | style="width: 153px; border: 1pt solid windowtext;" width="74" | Diabetes | ||
| + | | style="width: 125px; border: 1pt solid windowtext;" width="76" | Renal disease | ||
| + | | style="width: 100px; border: 1pt solid windowtext;" width="76" | Kidney function | ||
| + | |- | ||
| + | | style="width:40.05pt; border:solid windowtext 1.0pt" width="53" | [[Wilkinson|Wilkinson DC]] | ||
| + | | style="width:41.0pt; border:solid windowtext 1.0pt" width="55" | Chapman IM | ||
| + | | style="width:41.05pt; border:solid windowtext 1.0pt" width="55" | Heilbronn LK | ||
| + | | style="width: 221px; border: 1pt solid windowtext;" width="121" | Hyperbaric oxygen but not hyperbaric air increases insulin sensitivity in men with type 2 diabetes mellitus. | ||
| + | | style="width: 93px; border: 1pt solid windowtext;" width="74" | Diving Hyperb Med. 2020 Dec 20;50(4):386-390. | ||
| + | | style="width: 153px; border: 1pt solid windowtext;" width="74" | Diabetes | ||
| + | | style="width: 125px; border: 1pt solid windowtext;" width="76" | Insulin sensitivity | ||
| + | | style="width: 100px; border: 1pt solid windowtext;" width="76" | Hyperbaric air | ||
| + | |} | ||
| + | <p style="text-align: center;"><br/> <span style="font-size:x-large;">[[Home|HOME]] [[Index_page|INDEX]] [[Search_Database|SEARCH DATABASE]] [[What_is_a_CAT?|WHAT IS A CAT?]] [[What_can_I_do?|WHAT CAN YOU DO?]] [[Introduction|INTRODUCTION]] [[What_is_hyperbaric_medicine?|HBO EXPLAINED]]</span></p> | ||
[[File:Sumhorsa.gif|center|Sumhorsa.gif]] | [[File:Sumhorsa.gif|center|Sumhorsa.gif]] | ||
[[Category:Physiology]] | [[Category:Physiology]] | ||
Latest revision as of 01:06, 25 April 2022
PHYSIOLOGY AND PHARMACOLOGY+POST-SURGICAL EFFECTS
HOME INDEX SEARCH DATABASE WHAT IS A CAT?WHAT CAN YOU DO? INTRODUCTION HBO EXPLAINED
Dealing with the physiology or pharmacology of compression and/or hyperoxygenation + the postoperative use of HBOT
Subject last searched June 2017. Next search January 2022
Author 1 |
Author 2 |
Author 3 |
Title |
Citation |
Keyword 1 |
Keyword 2 |
Keyword 3 |
|
Slade JB |
Influence of hyperbaric oxygen on the pharmacokinetics of single-dose gentamicin in healthy volunteers. |
Pharmacotherapy 1993;13(4):382-5. |
Gentamicin |
Pharmacokinetics | |||
|
Rocco M |
De Blasi R |
Assessment of lipid peroxidation in hyperbaric oxygen therapy: protective role of N-acetylcysteine. |
Minerva Anestesiologia 1995; 61:133-139. |
Acetylcysteine |
Lipid Peroxidation |
Free Radicals | |
|
Abramovich A |
Adir Y |
Effects on pulmonary function of daily exposure to dry or humidified hyperbaric oxygen. |
Respiratory Physiology 1997; 108:241-246. |
Humidity |
Respiratory Mechanics | ||
|
Hakim TS |
Trang LQ |
The synergistic effect of sympathectomy and hyperbaric oxygen exposure on transcutaneous PO2 in healthy volunteers |
Anesthesia and Analgesia 1999; 88:67-71 |
Nerve Block |
*Sympathectomy/Chemical |
Blood Gas Monitoring, Transcutaneous | |
|
Frey M |
Mohler S |
Effect of caffeine consumption on tissue oxygen levels during hyperbaric oxygen treatment. |
Undersea and Hyperbaric Medicine 1999; 26:93-97. |
Caffeine/administration |
Blood gas monitoring, transcutaneous | ||
|
Tanabe G |
Kihara K |
Early post-operative hyperbaric oxygen therapy modifies neutrophile activation |
Hepato-Gastroenterology 1999; 46:1798-1799 |
Neutrophil |
Hepatectomy |
Endothelium | |
|
Mortensen CR |
Tvede MF |
It is possible to perform a double-blind hyperbaric session: A double-blinded randomized trial performed on healthy volunteers. |
Undersea and Hyperbaric Medicine 2009;36(5):347-351 |
Blinding |
Trial methodology |
RCT | |
|
Sakoda M |
Kurahara H |
Safety and efficacy of early postoperative hyperbaric oxygen therapy with restriction of transfusions in patients with HCC who have undergone partial hepatectomy. |
Langenbeck's archives of surgery. 2011 Jan 1;396(1):99-106 |
Hepatectomy |
Serum Lactate |
Complications | |
|
Staff I |
Johnson-Arbor K |
A Double-Blind, Randomized Trial on the Efficacy and Safety of Hyperbaric Oxygenation Therapy in the Preservation of Erectile Function after Radical Prostatectomy. |
The Journal of Urology 2018; 199:805-811. |
Prostatectomy |
Erectile dysfunction |
Quality of Life | |
|
Noronha JM |
Sette MF |
Cardiorespiratory alterations in patients undergoing hyperbaric oxygen therapy. |
Revista da Escola de Enfermagem da USP. 2019 Sep;53:e03469 |
Oxygen saturation |
Heart rate |
Respiratory | |
| Chen F | Sun H | Jia B | Clinical studies on the use of hyperbaric oxygen in replantation of young permanent teeth. | Zhonghua kou qiang yi xue za zhi= Zhonghua kouqiang yixue zazhi= Chinese journal of stomatology. 2000 Jul 1;35(4):271-3 | tooth implantation | dentistry | Re-implantation |
| Cardenas Ureña KG | Ramírez Nava JC | Márquez Celedonio FG | Clinical efficacy of adjuvant therapy with hyperbaric oxygen in diabetic nephropathy. | Undersea & Hyperbaric Medicine 2020, 47(3): 415-422. | Diabetes | Renal disease | Kidney function |
| Wilkinson DC | Chapman IM | Heilbronn LK | Hyperbaric oxygen but not hyperbaric air increases insulin sensitivity in men with type 2 diabetes mellitus. | Diving Hyperb Med. 2020 Dec 20;50(4):386-390. | Diabetes | Insulin sensitivity | Hyperbaric air |
HOME INDEX SEARCH DATABASE WHAT IS A CAT? WHAT CAN YOU DO? INTRODUCTION HBO EXPLAINED
